Bio-Cat partners with Caldic North America to distribute probiotics in the North American companion animal market
Bio-Cat Inc. has announced a partnership with Caldic North America, to distribute Bio-Cat’s branded probiotic strains, such as Optifeed to the companion animal health and nutrition market in North America.
Photo © iStockphoto.com/BilevichOlga
Bio-Cat Inc. (Troy, VA) has announced a partnership with Caldic North America (Mississauga, ON, Canada), to distribute Bio-Cat’s branded probiotic strains, such as Optifeed to the companion animal health and nutrition market in North America. According to the company’s press release, the agreement “secures a rapid go-to-market strategy for Bio-Cat, leveraging Caldic's leadership position in the companion animal market as a provider of value-add antioxidant, vitamin, mineral, and ingredient solutions.”
Optifeed is produced by Bio-Cat Microbials, in Shakopee, MN, in a vertically integrated, FDA-registered, and SQF-certified U.S. fermentation facility. The AAFCO-listed probiotic strains in Optifeed are designed to support the gastrointestinal health of companion animals. Bio-Cat also states that the Optifeed line will expand to enzymes in the future to further enhance the digestive health benefits and nutritional value of pet foods, with potential use in ingredient processing and flavor development.
"This partnership with Bio-Cat significantly strengthens Caldic's existing companion animal portfolio, adding a range of innovative and customizable solutions to inspire quality pet food and health," says Liz Parker, director of companion animal health & nutrition, for Caldic North America, in a press release. "As the importance of pet companionship is widely recognized, domestic animal owners are increasingly keen to provide their pets with nutritionally high-performing food, treats and supplements. The expert know-how our R&D team has acquired in pet food when formulating with our antioxidants range, Dadex, and our custom vitamin and mineral blends, Daminaide, will greatly benefit the solutions we can deliver across North America while partnering with Bio-Cat."
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.
